Quote For Abbott Laboratories ABT.N
Abbott Laboratories (ABT.N) (New York Stock Exchange)
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
$54.24
24 Nov 2009
+2.09%
$53.13
$53.22
2,846,700
$54.49
$52.50
$57.39
$41.27
0.22
6,210,105
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| White, Miles | Chairman of the Board, Chief Executive Officer | 28,335,494 |
| Freyman, Thomas | Chief Financial Officer, Executive Vice President - Finance | 6,847,843 |
| Tyree, James | President of Abbott Biotech Ventures Inc | 6,232,208 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $83,895.09 |
| Shares Outstanding (Mil.) | 1,546.74 |
| Float (Mil.) | 1,542.90 |
| Dividend Information | |
|---|---|
| Yield % | 2.95 |
| Annual Dividend ($ USD) | 1.44 |
| Payout Ratio(TTM) % | 43.13 |
| Financial Strength | |
|---|---|
| Quick Ratio | 1.23 |
| Current Ratio | 1.71 |
| LT Debt/Equity | 54.26 |
| Total Debt/Equity | 73.37 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 15.08 |
| Price/Sales(TTM) | 2.80 |
| Price/Book(TTM) | 3.93 |
| Price/Cash Flow(TTM) | 11.09 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $3.62 |
| Sales(TTM) | $19.23 |
| Book Value(MRQ) | $13.79 |
| Cash Flow(TTM) | $4.86 |
| Cash(MRQ) | $5.62 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 27.52 |
| Return on Assets(TTM) | 12.22 |
| Return on Investment(TTM) | 16.11 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 57.88 |
| Operating Margin(TTM) % | 20.43 |
| Profit Margin(TTM) % | 18.70 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
